![Jim L. Goode](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim L. Goode
Sales & Marketing at Pegasus Biologics, Inc.
Profile
Jim L.
Goode is Vice President of Sales for Pegasus Biologics, Inc. Prior to joining Pegasus in February 2008, he was Vice President of Sales and Marketing for Virturad, Inc. Before joining Oratec, Mr. Goode was Vice President of Sales at Curon, Inc. Previously, he was National Sales Director at Oratec Interventions.
Mr. Goode began his medical sales career at Stryker Corp.
as a Sales and Marketing Executive for nine years.
He has over 17 years of experience in the orthopaedic, cardiology and GI medical device fields.
Mr. Goode received a BS degree in Psychology and Pre-Medical Sciences from the University of Colorado.
Jim L. Goode active positions
Companies | Position | Start |
---|---|---|
Pegasus Biologics, Inc.
![]() Pegasus Biologics, Inc. Medical SpecialtiesHealth Technology Pegasus Biologics, Inc. engages in manufacturing, developing, and marketing bioimplants for soft tissue repair and wound care for diabetic ulcers. Its products include Unite Biomatrix and OrthADAPT Bioimplant. Pegasus Biologics serves orthopedics, sports medicine, neurosurgical, and spine applications. The company is headquartered in Irvine, CA | Sales & Marketing | - |
Former positions of Jim L. Goode
Companies | Position | End |
---|---|---|
ORATEC Interventions, Inc.
![]() ORATEC Interventions, Inc. Medical SpecialtiesHealth Technology ORATEC Interventions, Inc. develops and markets medical devices that use controlled thermal energy to treat spine and joint disorders. The company markets two minimally invasive systems: the SpineCATH IntraDiscal ElectroThermal Therapy (IDET) system and the ElectroThermal Arthroscopy system. The company markets its products directly to orthopedic surgeons, neurosurgeons and pain management specialists. | Sales & Marketing | - |
STRYKER CORPORATION | Sales & Marketing | - |
Curon Medical, Inc.
![]() Curon Medical, Inc. Pharmaceuticals: MajorHealth Technology Curon Medical, Inc. develops, manufactures and markets proprietary products for the treatment of gastrointestinal disorders. Its products consist of radiofrequency generators and single-use disposable devices. The company was founded on May 1, 1997 and is headquartered in Fremont, CA. | Sales & Marketing | - |
Training of Jim L. Goode
The University of Colorado | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
STRYKER CORPORATION | Health Technology |
Private companies | 3 |
---|---|
Pegasus Biologics, Inc.
![]() Pegasus Biologics, Inc. Medical SpecialtiesHealth Technology Pegasus Biologics, Inc. engages in manufacturing, developing, and marketing bioimplants for soft tissue repair and wound care for diabetic ulcers. Its products include Unite Biomatrix and OrthADAPT Bioimplant. Pegasus Biologics serves orthopedics, sports medicine, neurosurgical, and spine applications. The company is headquartered in Irvine, CA | Health Technology |
Curon Medical, Inc.
![]() Curon Medical, Inc. Pharmaceuticals: MajorHealth Technology Curon Medical, Inc. develops, manufactures and markets proprietary products for the treatment of gastrointestinal disorders. Its products consist of radiofrequency generators and single-use disposable devices. The company was founded on May 1, 1997 and is headquartered in Fremont, CA. | Health Technology |
ORATEC Interventions, Inc.
![]() ORATEC Interventions, Inc. Medical SpecialtiesHealth Technology ORATEC Interventions, Inc. develops and markets medical devices that use controlled thermal energy to treat spine and joint disorders. The company markets two minimally invasive systems: the SpineCATH IntraDiscal ElectroThermal Therapy (IDET) system and the ElectroThermal Arthroscopy system. The company markets its products directly to orthopedic surgeons, neurosurgeons and pain management specialists. | Health Technology |
- Stock Market
- Insiders
- Jim L. Goode